|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-3-14
|
|
pubmed:abstractText |
The Percutaneous Coronary Intervention-Clopidogrel in Unstable Angina to Prevent Recurrent Events (PCI-CURE) study, which examined the effect of adding clopidogrel to aspirin versus aspirin alone in patients with unstable coronary artery disease (CAD) undergoing PCI, found a relative risk reduction in cardiovascular deaths and myocardial infarction among those treated with clopidogrel. In addition, a within-trial cost-effectiveness analysis showed favorable costs per event avoided. However, to estimate the long-term effects, a modeling approach is necessary.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
100-10
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15763611-Aged,
pubmed-meshheading:15763611-Aged, 80 and over,
pubmed-meshheading:15763611-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15763611-Aspirin,
pubmed-meshheading:15763611-Computer Simulation,
pubmed-meshheading:15763611-Coronary Disease,
pubmed-meshheading:15763611-Cost-Benefit Analysis,
pubmed-meshheading:15763611-Drug Administration Schedule,
pubmed-meshheading:15763611-Drug Costs,
pubmed-meshheading:15763611-Drug Therapy, Combination,
pubmed-meshheading:15763611-Female,
pubmed-meshheading:15763611-Humans,
pubmed-meshheading:15763611-Logistic Models,
pubmed-meshheading:15763611-Male,
pubmed-meshheading:15763611-Markov Chains,
pubmed-meshheading:15763611-Middle Aged,
pubmed-meshheading:15763611-Models, Economic,
pubmed-meshheading:15763611-Monte Carlo Method,
pubmed-meshheading:15763611-Platelet Aggregation Inhibitors,
pubmed-meshheading:15763611-Ticlopidine,
pubmed-meshheading:15763611-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
|
|
pubmed:affiliation |
Department of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden. peter.lindgren@imm.ki.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
